297 related articles for article (PubMed ID: 16540796)
21. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
22. PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse.
Delayre-Orthez C; Becker J; Guenon I; Lagente V; Auwerx J; Frossard N; Pons F
Respir Res; 2005 Aug; 6(1):91. PubMed ID: 16091136
[TBL] [Abstract][Full Text] [Related]
23. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724
[TBL] [Abstract][Full Text] [Related]
24. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
Mazzucotelli A; Viguerie N; Tiraby C; Annicotte JS; Mairal A; Klimcakova E; Lepin E; Delmar P; Dejean S; Tavernier G; Lefort C; Hidalgo J; Pineau T; Fajas L; Clément K; Langin D
Diabetes; 2007 Oct; 56(10):2467-75. PubMed ID: 17646210
[TBL] [Abstract][Full Text] [Related]
25. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
Ostrowski LE; Yin W; Diggs PS; Rogers TD; O'Neal WK; Grubb BR
Gene Ther; 2007 Oct; 14(20):1492-501. PubMed ID: 17637798
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
27. Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise.
Lamhonwah AM; Bear CE; Huan LJ; Kim Chiaw P; Ackerley CA; Tein I
Ann Neurol; 2010 Jun; 67(6):802-8. PubMed ID: 20517942
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of cystic fibrosis transmembrane conductance regulator and Na+,K+ -ATPase in gills of striped bass, Morone saxatilis: effect of salinity and hormones.
Madsen SS; Jensen LN; Tipsmark CK; Kiilerich P; Borski RJ
J Endocrinol; 2007 Jan; 192(1):249-60. PubMed ID: 17210762
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation.
Shen H; Fan Y; Yang X; Burczynski FJ; Li P; Gong Y
J Cell Physiol; 2005 Jun; 203(3):599-603. PubMed ID: 15605366
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
Sun L; Ke Y; Zhu CY; Tang N; Tian DK; Gao YH; Zheng JP; Bian K
Chin Med J (Engl); 2008 Nov; 121(22):2305-11. PubMed ID: 19080338
[TBL] [Abstract][Full Text] [Related]
31. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
Hsu SC; Huang CJ
J Nutr Biochem; 2007 Feb; 18(2):86-96. PubMed ID: 16713235
[TBL] [Abstract][Full Text] [Related]
32. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.
Ramakers JD; Verstege MI; Thuijls G; Te Velde AA; Mensink RP; Plat J
J Clin Immunol; 2007 May; 27(3):275-83. PubMed ID: 17510806
[TBL] [Abstract][Full Text] [Related]
33. PPARα contributes to colonic protection in mice with DSS-induced colitis.
Azuma YT; Nishiyama K; Matsuo Y; Kuwamura M; Morioka A; Nakajima H; Takeuchi T
Int Immunopharmacol; 2010 Oct; 10(10):1261-7. PubMed ID: 20650341
[TBL] [Abstract][Full Text] [Related]
34. PPARalpha is a key regulator of hepatic FGF21.
Lundåsen T; Hunt MC; Nilsson LM; Sanyal S; Angelin B; Alexson SE; Rudling M
Biochem Biophys Res Commun; 2007 Aug; 360(2):437-40. PubMed ID: 17601491
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion.
Fiorotto R; Spirlì C; Fabris L; Cadamuro M; Okolicsanyi L; Strazzabosco M
Gastroenterology; 2007 Nov; 133(5):1603-13. PubMed ID: 17983806
[TBL] [Abstract][Full Text] [Related]
36. Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model.
Cohen JC; Morrow SL; Cork RJ; Delcarpio JB; Larson JE
Mol Genet Metab; 1998 Jun; 64(2):108-18. PubMed ID: 9705235
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase-12 gene regulation by a PPAR alpha agonist in human monocyte-derived macrophages.
Souissi IJ; Billiet L; Cuaz-Pérolin C; Slimane MN; Rouis M
Exp Cell Res; 2008 Nov; 314(18):3405-14. PubMed ID: 18823978
[TBL] [Abstract][Full Text] [Related]
38. Regulated expression of the human CFTR gene in epithelial cells.
Ye L; Chan S; Chow YH; Tsui LC; Hu J
Mol Ther; 2001 May; 3(5 Pt 1):723-33. PubMed ID: 11356077
[TBL] [Abstract][Full Text] [Related]
39. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
40. Association of cystic fibrosis with abnormalities in fatty acid metabolism.
Freedman SD; Blanco PG; Zaman MM; Shea JC; Ollero M; Hopper IK; Weed DA; Gelrud A; Regan MM; Laposata M; Alvarez JG; O'Sullivan BP
N Engl J Med; 2004 Feb; 350(6):560-9. PubMed ID: 14762183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
